Good day for biotech, tech markets

The BioCentury 100 and the NASDAQ Composite moved up 4.7% and 4.9%, respectively, on Monday, as investors revisited some of the shunned technology names like Cisco (CSCO). On the biotech front, upgrades from Robertson, Stephens analyst Mike King of Neurocrine Biosciences (NBIX), Vertex (VRTX), and Human Genome Sciences (HGSI) drove buying, as did a bullish article in the latest Barron's highlighting the progress made by the industry in combating cancer, fresh off last week's American Society of Clinical Oncology meeting in San Francisco. ...